A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (how the drug concentrations
change over time) of abiraterone acetate after oral administration of abiraterone acetate at
different dose levels of 250, 500, and 1000 mg in healthy Chinese male participants under
fasted conditions.